Showing results (151-160 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|March 6, 2026
Deep multi-omics profiling reveals three molecular subtypes of chronic obstructive pulmonary disease in a unique biomass-exposed Chinese populationWenqian Wu, Minyu Zhou, Junye Chen, et al.Med (New York, N.Y.)|March 28, 2024
Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic strokeMasahito Kawabori, Satoshi Kuroda, Hideo Shichinohe, et al.Med (New York, N.Y.)|March 23, 2024
The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccinationHing Wai Tsang, Mike Yat Wah Kwan, Gilbert T Chua, et al.Med (New York, N.Y.)|February 15, 2024
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinJoshua D Rosenblat, Shakila Meshkat, Zoe Doyle, et al.Med (New York, N.Y.)|February 15, 2024
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVIDKirsten Baillie, Helen E Davies, Samuel B K Keat, et al.Med (New York, N.Y.)|March 12, 2024
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosisAnne Knisely, Emily Hinchcliff, Bryan Fellman, et al.Med (New York, N.Y.)|April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysisTsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.Med (New York, N.Y.)|March 31, 2026
Autism spectrum disorder in China: Clinical practices, challenges, and futureNing Yang, Jun Wang, Hongmin Zhu, et al.Med (New York, N.Y.)|April 13, 2024
Rethinking strategies in SCLC: Lessons learned from tiragolumab in the SKYSCRAPER-02 studyJuan Carlos Laguna, Laura MezquitaPageof 87